(Circulation. 2001;104:903.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Internal Medicine (V.A., M.W., A.S.M.S., V.K.S.), Mayo Clinic, Rochester, Minn; the Department of Psychology (A.W.), University of North Dakota, Grand Forks; and the Department of Psychology (A.K.J.), University of Iowa, Iowa City.
Correspondence to Virend K. Somers, MD, PhD, Division of Hypertension and Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail somers.virend{at}mayo.edu
| Abstract |
|---|
|
|
|---|
Methods and Results We studied 11 subjects (9 females, 2 males) who had a history of syncope or presyncope only in response to a blood or injury stimulus and 11 healthy matched controls (10 females, 1 male) without a history of syncope. Blood pressure (BP) and heart rate (HR) were measured during a 15-minute baseline period with subjects in the supine position and then during 45 minutes of head-up tilt to 70°. Measurements at rest did not differ between the blood phobic and control subjects. During tilt, 9 (82%) of the 11 blood phobic subjects experienced presyncope or syncope, leading to termination of the study after 22±17 minutes of tilt. Only 1 (9%) of the 11 control subjects experienced presyncope (
2=11.7, P=0.001). Hemodynamic responses to tilt were consistent with a vasovagal mechanism in the blood phobic subjects, with simultaneous decreases in BP and HR during tilt. During tilt, systolic BP fell by 21±15 mm Hg (P=0.001), and HR fell by 22±25 bpm (P=0.01). By contrast, BP and HR were very stable in the control group.
Conclusions Subjects with syncope related to blood/injury phobia have an underlying autonomic dysregulation predisposing them to neurally mediated syncope, even in the absence of any blood or injury stimulus. Fainting related to these stimuli may in large part be due to dysfunction in neural circulatory control, which may secondarily lead to the phobia because of repeated syncopal events.
Key Words: syncope nervous system, autonomic blood pressure heart rate
| Introduction |
|---|
|
|
|---|
80% of the cases,4,5 the phobic response is characterized by syncope or presyncope. This response is peculiar to blood phobia and is not a characteristic of other specific phobias. The mechanism underlying the syncope/presyncope associated with blood phobia is poorly understood. There is a lack of agreement between the various different hypotheses directed at explaining the unique response patterns of subjects with blood phobia.5 Several studies suggest complex interactions between psychological and physiological mechanisms as a basis for the fainting, such as parasympathetic conditioning from fear reactions or an innate idiosyncratic physiological circuitry.6,7 Although it is believed that vasovagal mechanisms may contribute to the syncope, this has not been well characterized. Furthermore, it is not known whether there is an underlying predisposition to vasovagal syncope, even in the absence of the blood phobia emotional response. In other words, do these individuals have an abnormality in autonomic circulatory control, with the blood phobia syncopal response being a manifestation of the susceptible substrate? Alternatively, do they faint only because of the profound nature of the emotional response to blood or injury, being otherwise resistant to fainting by any other provocation?
Tilt table testing is widely recognized as an effective technique for providing direct evidence of susceptibility to vasovagal syncope. Symptomatic hypotension and bradycardia during head-up tilt is consistent with neurally mediated vasovagal syncope.8 To our knowledge, there have been no previous studies of the response to head-up tilt in patients with blood phobic syncopal responses. We tested the hypothesis that subjects who experience fainting only in response to blood or injury stimuli have a constitutional autonomic substrate that predisposes them to vasovagal syncope during head-up tilt, even in the absence of a blood or injury stimulus. Therefore, we evaluated the responses to tilt in blood or injury phobic subjects compared with responses to tilt in control subjects.
| Methods |
|---|
|
|
|---|
|
Protocol and Measurements
All studies were performed in the late morning or early afternoon in subjects after a 3-hour fast. No other dietary or fluid restrictions were imposed on the subjects. Body straps and a foot rest were used to provide support during the tilt and to minimize muscle contraction. Blood pressure (BP) was measured by use of a Dinamap automatic sphygmomanometer. Heart rate (HR) was monitored by ECG. Measurements were obtained during a 15-minute baseline period with the subjects in the supine position and then during 45 minutes of head-up tilt to 70°, followed by a 15-minute period of recovery, again with subjects in the supine position. Subjects did not undergo any needle sticks or any other form of invasive or noxious measurements or instrumentation. Studies were discontinued early if syncope occurred. Furthermore, in the event of presyncopal symptoms (such as lightheadedness, blurred vision, or severe anxiety), all subjects were free to request discontinuation of the tilt test.
Data Analysis
Baseline data were the mean measurements during the 5 minutes preceding tilt. Mean data were calculated for the first 3 minutes of tilt (start tilt) and during the last minute of tilt (end tilt) before termination. For the symptomatic subjects, the test was terminated at 22±17 minutes after starting the tilt. Therefore, for the purposes of hemodynamic measurements in the asymptomatic subjects, the end tilt was also established as the 22nd minute of the tilt (the same as the average end-tilt timing in the symptomatic subjects), so that comparable durations of tilt could be used for both symptomatic and asymptomatic groups.
HR was calculated as the mean for each minute, except for the end-tilt period in the symptomatic subjects (syncopal and presyncopal), when it was calculated over
15 seconds at the end of the tilt.
Statistical Analysis
A
2 analysis was used to compare categorical variables with the Fisher exact test. The differences in the hemodynamic variables within the same group in different periods and the differences between groups in the same time period were assessed by paired or unpaired Student t test, where appropriate. Anthropometric data were expressed as mean±SD; the other data were expressed as mean±SE. Data were further analyzed as repeated-measures ANOVA, with time as within factor and group as between factor. Values were adjusted for sex, age, and body mass index. A value of P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
During the tilt test, 9 (82%) of the 11 blood phobic subjects experienced presyncopal or syncopal symptoms, which led to termination of the study at the subjects request. Only 1 (9%) of the 11 control subjects experienced presyncope. Ten of the 11 control subjects completed the 45 minutes of tilt without symptoms or significant hemodynamic changes (
2=11.7, P=0.001) (Figure 1). Tilt duration averaged 43±7 minutes in the control subjects and 22±17 minutes in the blood phobic subjects (P=0.001).
|
In comparing the peak HR and BP levels during tilt, the blood phobic subjects had an enhanced HR response and an attenuated BP response compared with respective responses in control subjects. Compared with the baseline period, during tilt, HR increased more in the blood phobic subjects than in the control subjects (by 33±12 versus 25±10 bpm, respectively; F=4.30, P=0.05). In contrast, the blood phobic subjects, compared with the control subjects, had a significantly blunted increase in systolic BP (SBP; 11±6 versus 17±7 mm Hg, respectively; F=7.12, P=0.016).
Comparing the start-tilt and end-tilt periods, SBP and HR dropped significantly in the blood phobic group. SBP fell by 21±15 mm Hg (P=0.001), and HR fell by 22±25 bpm (P=0.01) (Figures 2, 3, and 4; Table 2). In contrast SBP and HR were very stable in the control group: comparing start tilt with end tilt in control subjects, SBP fell by 2±13 mm Hg (P=NS), and HR increased by 2±10 bpm (P=NS) (Figure 2, Table 2).
|
|
|
|
SBP and HR were also significantly different between blood phobic subjects and control subjects at end tilt (SBP 90±20 versus 110±15 mm Hg, respectively [P=0.02]; HR 67±25 versus 85±10 bpm, respectively [P=0.03]).
Thus, even though baseline hemodynamic measures were not significantly different, the difference in response during tilt and at the end of tilt in blood phobic subjects versus control subjects was significant for both HR and BP in the multivariate analysis of ANOVA (Figure 2, Table 2).
| Discussion |
|---|
|
|
|---|
Blood/injury phobia is very different from the other categories of the specific phobias. It is highly familial3,6,10 and is usually not associated with other psychiatric disorders, such as agoraphobia, social phobia, anxiety, panic, or depression. Furthermore, the association with fainting is not common to the other phobias.6,10 Previous studies of the syncopal event during a phobic stimulus have described a biphasic cardiovascular response. When first confronted with the phobic stimulus, these individuals exhibit increased BP and HR. This response is common to all the specific phobias. Soon after, there is bradycardia and hypotension, with consequent reduced blood supply to the brain, which leads to syncope.4,5,11,12 Thus, there is a precedent to suggest that fainting during blood exposure is vasovagally mediated.
Humans have a natural fear of blood and injury. Discomfort, nausea, HR changes, lightheadedness, and feeling faint are not unusual in the normal population when they are confronted with these situations.6 Typical examples encountered in the clinical setting include the fainting of medical students at the sight of blood or autopsies. Vasovagal syncope is also widely described among blood donors (an incidence of 1% to 15%),4,13,14 especially during their first experience, and also among dental patients. Bradycardia has also been reported in normal subjects and in medical audiences on viewing violent films.15 The origins of these reactions have been addressed in an evolutionary context.16,17 Human fainting in response to blood/injury stimuli may be a trait evolved from the tonic immobility or "playing dead" observed in many animal species when confronted with specific fears. During this reaction, bradycardia and vasodilatation have been observed.1618 This "emotional fainting" could be a physiological activation of a specific evolutionary reflex rather than an acquired cultural phenomenon.6
What is it that differentiates the blood phobic subjects from the normal population, in whom the fear of blood or injury also occurs? In other words, why should a natural fear evolve into a phobia? It has been hypothesized that fainting in association with the fear accompanying blood or injury exposure may occur in people who easily faint and that these subjects become more afraid of fainting and will avoid the blood or injury situation so as to avoid fainting.6 The strong familial component and the absence of other psychiatric conditions in these patients, and the usual absence of blood or injury phobia in patients with other psychiatric pathologies, further support the concept that a specific autonomic pattern of response, as a constitutional individual characteristic, is the basis for this fainting. Our results are consistent with this hypothesis, showing that compared with normal subjects, subjects with blood or injury phobia have an abnormal hemodynamic response during head-up tilt and are strikingly prone to vasovagal reactions. Fainting related to blood or injury stimuli may not be primarily due to a psychiatric condition but rather due to dysfunction in the autonomic nervous system, which may secondarily lead to the phobia because of repeated syncopal events.
Our data showing susceptibility to vasovagal syncope in patients with syncope accompanying blood phobia suggest that in addition to behavioral therapy, these individuals may benefit from pharmacological interventions that are effective in the treatment of vasovagal syncope. We speculate that pharmacologically induced attenuation of syncopal episodes may even contribute to amelioration of the phobia itself.
Our data further imply that blood phobic subjects would be predisposed to vasovagal syncope in normal life and in other nonphobic situations. We are not aware that the natural history of the blood phobic syncope response has been evaluated to address this question. Monitoring any possible changes in the clinical history of these subjects, such as an increased tendency to develop neurally mediated syncope, could help in the general understanding of syncope mechanisms and contribute to understanding the continuum of disorders of orthostatic tolerance.19,20
Limitations of the present study include the following: First, we permitted subjects to interrupt the tilt test as their symptoms developed. This approach, which was followed to minimize any anxiety component, mitigated the development of overt syncope in some of our subjects. If the test had been continued further, it is clear that the hypotension and bradycardia evident in the blood phobic subjects would have been even more marked than is apparent in the results. Second, the absence of direct intraneural recordings of sympathetic nerve traffic further limits our ability to define, in our subjects, the presyncopal autonomic and hemodynamic profile, as has been described in other studies of vasovagal syncope.19 Third, our study subjects were mainly females. We cannot exclude sex-related differences in the responses that we observed.
In summary, we have shown that compared with normal control subjects, subjects with syncopal events related only to blood or injury phobia have a markedly higher prevalence of vasovagal responses to head-up tilt. Thus, these subjects have an abnormality in autonomic circulatory control that predisposes them to neurally mediated syncope, even in the absence of a blood or injury stimulus.
| Acknowledgments |
|---|
Received March 9, 2001; revision received June 7, 2001; accepted June 21, 2001.
| References |
|---|
|
|
|---|
2. Costello CG. Fears and phobias in women: a community study. J Abnorm Psychol. 1982; 91: 280286.[Medline] [Order article via Infotrieve]
3. American Psychiatric Association. Specific phobia (formerly simple phobia).In: Diagnostic and Statistical Manual for Mental DisordersFourth Edition:DSM-IV Washington, DC: American Psychiatric Association; 1994; 405411.
4. Thyer BA, Himle J, Curtis GC. Blood-injury-illness phobia: a review. J Clin Psychol. 1985; 41: 451459.[Medline] [Order article via Infotrieve]
5. Ost LG, Sterner U, Lindhal IL. Physiological responses in blood phobics. Behav Res Ther. 1984; 22: 109117.[Medline] [Order article via Infotrieve]
6.
Marks I. Blood-injury phobia: a review. Am J Psychiatry. 1988; 145: 12071213.
7.
Babock HH, Powell DH. Vasovagal fainting: deconditioning an autonomic syndrome. Psychosomatics. 1982; 23: 969973.
8. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table test for assessing syncope. J Am Coll Cardiol. 1996; 28: 263275.[Medline] [Order article via Infotrieve]
9. First MB, Spitzer RL, Gibbon M, et al. Specific phobia.In: Structured Clinical Interview for Axis I DSM-IV Disorders 1994. New York, NY: Biometrics Research Department; 1996: F16F19.
10. Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behav Res Ther. 1979; 17: 263267.[Medline] [Order article via Infotrieve]
11. Kleinknecht RA, Lenz J. Blood/injury fear, fainting and avoidance of medically-related situations: a family correspondence study. Behav Res Ther. 1989; 27: 537547.[Medline] [Order article via Infotrieve]
12.
Steptoe A, Wardle J. Emotional fainting and the psychophysiologic response to blood and injury: autonomic mechanisms and coping strategies. Psychosom Med. 1988; 50: 402417.
13. Ogata H, Iinuma N, Nagashima K, et al. Vasovagal reactions in blood donors. Transfusion. 1980; 20: 679683.[Medline] [Order article via Infotrieve]
14.
Graham DT. Prediction of fainting in blood donors. Circulation. 1961; 23: 901906.
15. Carruthers M, Taggart P. Vagotonicity of violence: biochemical and cardiac responses to violent films and television programs. BMJ. 1973; 3: 384389.
16. Marks IM. Fears, Phobias and Rituals: Panic, Anxiety and Their Disorders. New York, NY: Oxford University Press; 1987.
17. Nash RF, Gallup GGJr, Czech DA. Psychophysiological correlates of tonic immobility in domestic chicken (Gallus gallus). Physiol Behav. 1976; 17: 413418.[Medline] [Order article via Infotrieve]
18. Hebb DO. On the nature of fear. Psychol Rev. 1946; 53: 259276.
19.
Furlan R, Piazza S, DellOrto S, et al. Cardiac autonomic patterns preceding occasional vasovagal reactions in healthy humans. Circulation. 1998; 98: 17561761.
20.
Narkiewicz K, Somers VK. Chronic orthostatic intolerance: part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis? Circulation. 1998; 98: 21052107.
This article has been cited by other articles:
![]() |
S. Alamy, Wei Zhang, I. Varia, J. R. Davidson, and K. M Connor Escitalopram in specific phobia: results of a placebo-controlled pilot trial J Psychopharmacol, March 1, 2008; 22(2): 157 - 161. [Abstract] [PDF] |
||||
![]() |
N. van Dijk, M. C. Boer, T. De Santo, N. Grovale, A. J.J. Aerts, L. Boersma, and W. Wieling Daily, weekly, monthly, and seasonal patterns in the occurrence of vasovagal syncope in an older population Europace, September 1, 2007; 9(9): 823 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Donadio, R. Liguori, M. Elam, T. Karlsson, P. Montagna, P. Cortelli, A. Baruzzi, and B. G. Wallin Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients Brain, June 1, 2007; 130(6): 1653 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gerlach, G. Spellmeyer, C. Vogele, R. Huster, S. Stevens, G. Hetzel, and J. Deckert Blood-injury phobia with and without a history of fainting: disgust sensitivity does not explain the fainting response. Psychosom Med, March 1, 2006; 68(2): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Fernandes Rapid Desensitization for Needle Phobia Psychosomatics, June 1, 2003; 44(3): 253 - 254. [Full Text] [PDF] |
||||
![]() |
A. L. Peterson, J. A. Cigrang, C.T. P. Krediet, N. van Dijk, J. J. van Lieshout, W. Wieling, and M. Linzer Management of Vasovagal Syncope: Controlling or Aborting Faints by Leg Crossing and Muscle Tensing * Response Circulation, May 27, 2003; 107 (20): e198 - e198. [Full Text] [PDF] |
||||
![]() |
P. Flevari, E. G. Livanis, G. N. Theodorakis, E. Zarvalis, T. Mesiskli, and D. T. h Kremastinos Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being J. Am. Coll. Cardiol., August 7, 2002; 40(3): 499 - 504. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |